JenaValve Technology Inc. is engaged in design, development, manufacturing and marketing of transcatheter aortic valve replacement systems (TAVI) to treat patients with severe aortic stenosis. JenaValve is a privately-held, venture capital backed U.S. corporation with operations in Munich, Germany. The Company's TAVI products are being sold primarily in Europe. Please visit for more information.
Company Growth (employees)
München, DE
Size (employees)
60 (est)-4%
JenaValve was founded in 2006 and is headquartered in München, DE

JenaValve Office Locations

JenaValve has offices in München and Irvine
München, DE (HQ)
25 Guerickestraße

JenaValve Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$112.5 m

Latest funding size

$26.5 m

Time since last funding

over 2 years
JenaValve's latest funding round in August 2015 was reported to be $26.5 m. In total, JenaValve has raised $112.5 m

JenaValve's Web-traffic and Trends

JenaValve Company Life and Culture

You may also be interested in